|
|
Volumn 14, Issue , 2013, Pages
|
|
Assessing the effectiveness and safety of liposomal paclitaxel in combination with cisplatin as first-line chemotherapy for patients with advanced NSCLC with regional lymph-node metastasis: study protocol for a randomized controlled trial (PLC-GC trial).
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
LIPOSOME;
PACLITAXEL;
ARTICLE;
CANCER STAGING;
CHEMISTRY;
CHINA;
CLINICAL PROTOCOL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE FREE SURVIVAL;
HUMAN;
KAPLAN MEIER METHOD;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
LYMPH NODE METASTASIS;
METASTASIS;
METHODOLOGY;
MORTALITY;
PATHOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMISTRY, PHARMACEUTICAL;
CHINA;
CISPLATIN;
CLINICAL PROTOCOLS;
DEOXYCYTIDINE;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
HUMANS;
KAPLAN-MEIER ESTIMATE;
LIPOSOMES;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
NEOPLASM STAGING;
PACLITAXEL;
PROSPECTIVE STUDIES;
RESEARCH DESIGN;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 84873721551
PISSN: None
EISSN: 17456215
Source Type: None
DOI: 10.1186/1745-6215-14-45 Document Type: Article |
|
Times cited : (15)
|
|
References (0)
|
